66 related articles for article (PubMed ID: 38609396)
1. Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
Jiménez-Vicente C; Charry P; Castaño-Diez S; Guijarro F; López-Guerra M; Pérez-Valencia AI; Martinez-Roca A; Cortés-Bullich A; Munárriz D; Solano MT; Rosiñol L; Carreras E; Urbano-Ispizua Á; Fernández-Avilés F; Martinez C; Suárez-Lledó M; Díaz-Beyá M; Rovira M; Salas MQ; Esteve J
Br J Haematol; 2024 May; ():. PubMed ID: 38811025
[TBL] [Abstract][Full Text] [Related]
2. [Update on the Diagnosis and Stratification of Patients with Acute Myeloid Leukemia: An Urgent National Need].
Jerez J; Briones JL; Buscaglia F; Torres C; Hidalgo S; Guerra MC; Goldschmidt V; Gazitúa R
Rev Med Chil; 2023 May; 151(5):628-638. PubMed ID: 38687545
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Acute Myeloid Leukemia Genomes using Genomic Proximity Mapping.
Yeung CC; Eacker SM; Sala-Torra O; Beppu L; Woolston DW; Liachko I; Malig M; Stirewalt D; Fang M; Radich J
medRxiv; 2024 Jun; ():. PubMed ID: 38853970
[TBL] [Abstract][Full Text] [Related]
4. Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.
Falini B; Dillon R
Blood Cancer Discov; 2024 Jan; 5(1):8-20. PubMed ID: 37917833
[TBL] [Abstract][Full Text] [Related]
5. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
Kiyoi H
Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.
Song GY; Kim HJ; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Kim MY; Cheong JW; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Choi CK; Kim HJ; Ahn JS; Kim DDH
Sci Rep; 2024 Apr; 14(1):8517. PubMed ID: 38609396
[TBL] [Abstract][Full Text] [Related]
7. ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Hansen DK; Kim J; Thompson Z; Hussaini M; Nishihori T; Ahmad A; Elmariah H; Faramand R; Mishra A; Davila ML; Khimani F; Lazaryan A; Sallman D; Liu H; Perez LE; Fernandez H; Nieder ML; Lancet JE; Pidala JA; Anasetti C; Bejanyan N
Transplant Cell Ther; 2021 Mar; 27(3):256.e1-256.e7. PubMed ID: 33781526
[TBL] [Abstract][Full Text] [Related]
8. Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
Oran B; Jimenez AM; De Lima M; Popat UR; Bassett R; Andersson B; Borthakur G; Bashir Q; Chen J; Ciurea SO; Jabbour E; Cortes J; Kebriaei P; Khouri IF; Qazilbash MH; Ravandi F; Rondon G; Lu X; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1405-1412. PubMed ID: 25840338
[TBL] [Abstract][Full Text] [Related]
9. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Bataller A; Garrido A; Guijarro F; Oñate G; Diaz-Beyá M; Arnan M; Tormo M; Vives S; de Llano MPQ; Coll R; Gallardo D; Vall-Llovera F; Escoda L; Garcia-Guiñon A; Salamero O; Sampol A; Merchan BM; Bargay J; Castaño-Díez S; Esteban D; Oliver-Caldés A; Rivero A; Mozas P; López-Guerra M; Pratcorona M; Zamora L; Costa D; Rozman M; Nomdedéu JF; Colomer D; Brunet S; Sierra J; Esteve J
Blood Adv; 2022 Feb; 6(4):1193-1206. PubMed ID: 34911079
[TBL] [Abstract][Full Text] [Related]
10. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
Boddu PC; Kadia TM; Garcia-Manero G; Cortes J; Alfayez M; Borthakur G; Konopleva M; Jabbour EJ; Daver NG; DiNardo CD; Naqvi K; Yilmaz M; Short NJ; Pierce S; Kantarjian HM; Ravandi F
Cancer; 2019 Apr; 125(7):1091-1100. PubMed ID: 30521114
[TBL] [Abstract][Full Text] [Related]
11. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Eckardt JN; Bill M; Rausch C; Metzeler K; Spiekermann K; Stasik S; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Krug U; Wörmann B; Hiddemann W; Görlich D; Sauerland C; Steffen B; Einsele H; Neubauer A; Burchert A; Schäfer-Eckart K; Berdel WE; Schliemann C; Krause SW; Hänel M; Hanoun M; Kaufmann M; Fransecky L; Braess J; Ruhnke L; Schetelig J; Middeke JM; Serve H; Baldus CD; Platzbecker U; Müller-Tidow C; Bornhäuser M; Herold T; Thiede C; Röllig C
Leukemia; 2023 Nov; 37(11):2282-2285. PubMed ID: 37679502
[No Abstract] [Full Text] [Related]
12. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Pollyea DA; Altman JK; Assi R; Bixby D; Fathi AT; Foran JM; Gojo I; Hall AC; Jonas BA; Kishtagari A; Lancet J; Maness L; Mangan J; Mannis G; Marcucci G; Mims A; Moriarty K; Mustafa Ali M; Neff J; Nejati R; Olin R; Percival ME; Perl A; Przespolewski A; Rao D; Ravandi F; Shallis R; Shami PJ; Stein E; Stone RM; Sweet K; Thota S; Uy G; Vachhani P; Cassara CJ; Freedman-Cass DA; Stehman K
J Natl Compr Canc Netw; 2023 May; 21(5):503-513. PubMed ID: 37156478
[TBL] [Abstract][Full Text] [Related]
13. Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
Rausch C; Rothenberg-Thurley M; Dufour A; Schneider S; Gittinger H; Sauerland C; Görlich D; Krug U; Berdel WE; Woermann BJ; Hiddemann W; Braess J; von Bergwelt-Baildon M; Spiekermann K; Herold T; Metzeler KH
Leukemia; 2023 Jun; 37(6):1234-1244. PubMed ID: 37041198
[TBL] [Abstract][Full Text] [Related]
14. Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Lo MY; Tsai XC; Lin CC; Tien FM; Kuo YY; Lee WH; Peng YL; Liu MC; Tseng MH; Hsu CA; Chen JC; Lin LI; Sun HI; Chuang YK; Ko BS; Tang JL; Yao M; Chou WC; Hou HA; Tien HF
Am J Hematol; 2023 May; 98(5):760-769. PubMed ID: 36861732
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
